comparemela.com

Latest Breaking News On - Factor bioscience inc - Page 1 : comparemela.com

Factor Bioscience Successfully Defends Three U.S. Patents Covering Foundational Methods for Therapeutic Gene Editing

Factor Bioscience Successfully Defends Three U.S. Patents Covering Foundational Methods for Therapeutic Gene Editing
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Massachusetts
United-states
Cambridge
Cambridgeshire
United-kingdom
Christopher-rohde
Wilson-sonsini-goodrich-rosati
Matt-angel
Technology-officer
Trademark-office
Factor-bioscience-inc
Covering-foundational-methods

Factor Bioscience Successfully Defends Three U.S. Patents Covering Foundational Methods For Therapeutic Gene Editing

-Patented methods relate to multiple allogeneic CAR T-cell therapies under clinical development for the treatment of B-cell lymphoma, chronic lympho

United-states
Massachusetts
Cambridge
Cambridgeshire
United-kingdom
Christopher-rohde
Wilson-sonsini-goodrich-rosati
Matt-angel
Trademark-office
Factor-bioscience-inc
Technology-officer
Bioscience-inc

Lineage Announces Initiation of Development Activities for Hypoimmune Pluripotent Cell Line for Neurology Indications Under Partnership With Eterna Therapeutics

Lineage Cell Therapeutics, Inc. ; class= js-l-obf link link blue

United-states
American
Matt-angel
Brianm-culley
Roche-group
Genentech
Eterna-therapeutics-inc
Factor-bioscience-inc
Exchange-commission
Lineage-cell-therapeutics-inc
Lineage-cell-therapeutics
Eterna-therapeutics

Eterna Therapeutics Appoints Matt Angel, Ph.D. as Chief Executive Officer and President

Eterna Therapeutics Appoints Matt Angel, Ph.D. as Chief Executive Officer and President
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Cambridge
Cambridgeshire
United-kingdom
Matt-angel
Charles-cherington
Eterna-therapeuticseterna
Exacis-biotherapeutics
Company-board-of-directors
Massachusetts-institute-of-technology
Princeton-university
Factor-bioscience-inc
Nasdaq

In a New Audio Interview, Toni Loudenbeck of Traders News Source Interviews Dr. Matt Angel, CEO Eterna Therapeutics

NEW YORK, NY / ACCESSWIRE / December 20, 2022 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap publicly traded companies recently issued

Eterna
Niedersachsen
Germany
Matt-angel
Toni-loudenbeck
Exacis-biotherapeutics
Mark-roberts
Massachusetts-institute-of-technology
Factor-bioscience-inc
Traders-news-source
Eterna-therapeutics
News-source

vimarsana © 2020. All Rights Reserved.